{"transactions":[{"id":4626249,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":76792,"kind":"person","name":"Zikria Dean","position":1,"cik":"0001877611","reported_name":"Zikria Dean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Restricted Stock Units","published_at":"2026-09-24T20:46:25.000Z","date":"2026-09-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One fourth (1/4) of the Restricted Stock Units shall vest quarterly, with the first vesting occurring on December 22, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One fourth (1/4) of the Restricted Stock Units shall vest quarterly, with the first vesting occurring on December 22, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These numbers have been adjusted to reflect the reverse stock split of the common stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-26-007398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877611/000168316826007398/ownership.xml","form_type":"4"}},{"id":4626248,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-09-24T20:45:35.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":4,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the reverse stock split of the Common Stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026."}],"balance_after":19,"derivative":{"underlying":"Common Stock","underlying_shares":4},"source":{"system":"sec-edgar","filing":"0001683168-26-007396","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316826007396/ownership.xml","form_type":"4"}},{"id":4626247,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CFO"}}],"security":"Common Stock","published_at":"2026-09-24T20:45:35.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2,"price":2.12,"value":4.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person forfeited 2 shares of Common Stock upon vesting and settlement of 4 outstanding Restricted Stock Units to cover tax withholdings, using the market price of the Issuer's Common Stock at the time of forfeiture."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the reverse stock split of the Common Stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026."}],"balance_after":27,"source":{"system":"sec-edgar","filing":"0001683168-26-007396","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316826007396/ownership.xml","form_type":"4"}},{"id":4626246,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CFO"}}],"security":"Common Stock","published_at":"2026-09-24T20:45:35.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."}],"balance_after":29,"source":{"system":"sec-edgar","filing":"0001683168-26-007396","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316826007396/ownership.xml","form_type":"4"}},{"id":732245,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-18T20:30:27.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":92,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."}],"balance_after":551,"derivative":{"underlying":"Common Stock","underlying_shares":92},"source":{"system":"sec-edgar","filing":"0001683168-26-004970","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316826004970/ownership.xml","form_type":"4"}},{"id":732244,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-18T20:30:27.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."}],"balance_after":618,"source":{"system":"sec-edgar","filing":"0001683168-26-004970","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316826004970/ownership.xml","form_type":"4"}},{"id":769905,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-20T23:51:59.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":false,"shares":2206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty percent (25%) of the grant of 35,294 Restricted Stock Units vested upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the fourth anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Twenty percent (25%) of the grant of 35,294 Restricted Stock Units vested upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":24265,"derivative":{"underlying":"Common Stock","underlying_shares":2206},"source":{"system":"sec-edgar","filing":"0001683168-26-004192","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316826004192/ownership.xml","form_type":"4"}},{"id":769904,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-20T23:51:59.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":true,"shares":2206,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of common stock."}],"balance_after":11030,"source":{"system":"sec-edgar","filing":"0001683168-26-004192","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316826004192/ownership.xml","form_type":"4"}},{"id":793998,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":49979,"kind":"person","name":"Lackey Melinda","position":1,"cik":"0001898184","reported_name":"Lackey Melinda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & SVP of Legal"}}],"security":"Employee Stock Option (Right to Purchase)","published_at":"2026-05-04T20:08:18.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as follows: (i) 25% upon the first anniversary of the grant date, and (ii) the remaining 75% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."}],"balance_after":45000,"derivative":{"exercise_price":0.96,"expiration_date":"2036-05-01","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001683168-26-003448","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898184/000168316826003448/ownership.xml","form_type":"4"}},{"id":804399,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":51937,"kind":"person","name":"Bolton Sheryle","position":1,"cik":"0001418947","reported_name":"Bolton Sheryle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-20T20:02:04.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.04,"value":10400.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001683168-26-003073","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1418947/000168316826003073/ownership.xml","form_type":"4"}},{"id":820160,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":30150,"kind":"person","name":"Valauri Christina Rizopoulos","position":1,"cik":"0002005448","reported_name":"Valauri Christina Rizopoulos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T13:49:13.000Z","date":"2026-04-01","kind":"purchase","planned":false,"acquired":true,"shares":19000,"price":0.9478,"value":18008.2,"ownership":{"direct":true},"balance_after":19000,"source":{"system":"sec-edgar","filing":"0001683168-26-002599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005448/000168316826002599/ownership.xml","form_type":"4"}},{"id":833616,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-20T01:14:41.000Z","date":"2026-03-18","kind":"exercise","planned":false,"acquired":false,"shares":92,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the reverse stock split of the common stock of Tivic Health Systems, Inc., which underwent a reverse stock split at a ratio of 1-for-17 on March 7, 2025."}],"balance_after":643,"derivative":{"underlying":"Common Stock","underlying_shares":92},"source":{"system":"sec-edgar","filing":"0001683168-26-002034","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316826002034/ownership.xml","form_type":"4"}},{"id":833615,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-20T01:14:41.000Z","date":"2026-03-18","kind":"exercise","planned":false,"acquired":true,"shares":92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the reverse stock split of the common stock of Tivic Health Systems, Inc., which underwent a reverse stock split at a ratio of 1-for-17 on March 7, 2025."}],"balance_after":526,"source":{"system":"sec-edgar","filing":"0001683168-26-002034","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316826002034/ownership.xml","form_type":"4"}},{"id":890566,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-20T21:19:42.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":8824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty percent (25%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the fourth anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Twenty percent (25%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":26471,"derivative":{"underlying":"Common Stock","underlying_shares":26471},"source":{"system":"sec-edgar","filing":"0001683168-26-001220","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316826001220/ownership.xml","form_type":"4"}},{"id":890565,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-20T21:19:42.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":8824,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."}],"balance_after":8824,"source":{"system":"sec-edgar","filing":"0001683168-26-001220","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316826001220/ownership.xml","form_type":"4"}},{"id":961106,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-23T01:45:14.000Z","date":"2025-12-18","kind":"exercise","planned":false,"acquired":false,"shares":736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."}],"balance_after":735,"derivative":{"underlying":"Common Stock","underlying_shares":736},"source":{"system":"sec-edgar","filing":"0001683168-25-009306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316825009306/ownership.xml","form_type":"4"}},{"id":961105,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-23T01:45:14.000Z","date":"2025-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":302,"price":1.87,"value":564.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person forfeited 302 shares of Common Stock upon vesting and settlement of 736 outstanding Restricted Stock Units to cover tax withholdings, using the market price of the Issuer's common stock at the time of forfeiture."}],"balance_after":434,"source":{"system":"sec-edgar","filing":"0001683168-25-009306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316825009306/ownership.xml","form_type":"4"}},{"id":961104,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-23T01:45:14.000Z","date":"2025-12-18","kind":"exercise","planned":false,"acquired":true,"shares":736,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."}],"balance_after":736,"source":{"system":"sec-edgar","filing":"0001683168-25-009306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316825009306/ownership.xml","form_type":"4"}},{"id":961145,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-22T20:44:46.000Z","date":"2025-12-18","kind":"exercise","planned":false,"acquired":false,"shares":14706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."}],"balance_after":14706,"derivative":{"underlying":"Common Stock","underlying_shares":14706},"source":{"system":"sec-edgar","filing":"0001683168-25-009305","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825009305/ownership.xml","form_type":"4"}},{"id":961144,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T20:44:46.000Z","date":"2025-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":5262,"price":1.87,"value":9839.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person forfeited 5,262 shares of Common Stock upon vesting and settlement of 14,706 outstanding Restricted Stock Units to cover tax withholdings, using the market price of the Issuer's common stock at the time of forfeiture."}],"balance_after":32691,"source":{"system":"sec-edgar","filing":"0001683168-25-009305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825009305/ownership.xml","form_type":"4"}},{"id":961143,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T20:44:46.000Z","date":"2025-12-18","kind":"exercise","planned":false,"acquired":true,"shares":14706,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."}],"balance_after":37953,"source":{"system":"sec-edgar","filing":"0001683168-25-009305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825009305/ownership.xml","form_type":"4"}},{"id":1033163,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-24T20:02:15.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":22541,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23247,"source":{"system":"sec-edgar","filing":"0001683168-25-007223","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825007223/ownership.xml","form_type":"4"}},{"id":1058345,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Purchase)","published_at":"2025-08-23T00:00:41.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Amendment No. 1 (\"Form 4/A\") to the Form 4 filed by the reporting person on August 8, 2025 (the \"Original Form 4\") is being filed to correct an administrative error, resulting in the incorrect vesting schedule for the stock option being included in the Original Form 4. As reflected in this Form 4/A, the stock option vests as follows: (i) 25% upon the first anniversary of the grant date, and (ii) the remaining 75% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."}],"balance_after":80000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001683168-25-006430","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316825006430/ownership.xml","form_type":"4/A","original_submission_date":"2025-08-08"}},{"id":1057736,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Purchase)","published_at":"2025-08-23T00:00:27.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Amendment No. 1 (\"Form 4/A\") to the Form 4 filed by the reporting person on August 8, 2025 (the \"Original Form 4\") is being filed to correct an administrative error, resulting in the incorrect vesting schedule for the stock option being included in the Original Form 4. As reflected in this Form 4/A, the stock option vests as follows: (i) 25% upon the first anniversary of the grant date, and (ii) the remaining 75% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."}],"balance_after":45000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001683168-25-006429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316825006429/ownership.xml","form_type":"4/A","original_submission_date":"2025-08-08"}},{"id":1058380,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Purchase)","published_at":"2025-08-22T20:00:13.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Amendment No. 1 (\"Form 4/A\") to the Form 4 filed by the reporting person on August 8, 2025 (the \"Original Form 4\") is being filed to correct an administrative error, resulting in the incorrect vesting schedule for the stock option being included in the Original Form 4. As reflected in this Form 4/A, the stock option vests as follows: (i) 25% upon the first anniversary of the grant date, and (ii) the remaining 75% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."}],"balance_after":85000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001683168-25-006428","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825006428/ownership.xml","form_type":"4/A","original_submission_date":"2025-08-08"}},{"id":1071449,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Purchase)","published_at":"2025-08-08T22:46:28.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as follows: (i) 50% upon the first anniversary of the grant date, and (ii) the remaining 50% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."}],"balance_after":80000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001683168-25-005836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316825005836/ownership.xml","form_type":"4"}},{"id":1071507,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":30150,"kind":"person","name":"Valauri Christina Rizopoulos","position":1,"cik":"0002005448","reported_name":"Valauri Christina Rizopoulos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-08-08T22:46:12.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in a series of four (4) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the grant date, such that 100% of the stock option will be vested upon the first anniversary of the grant date."}],"balance_after":7500,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001683168-25-005835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005448/000168316825005835/ownership.xml","form_type":"4"}},{"id":1071316,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Purchase)","published_at":"2025-08-08T22:45:52.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as follows: (i) 50% upon the first anniversary of the grant date, and (ii) the remaining 50% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."}],"balance_after":45000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001683168-25-005834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316825005834/ownership.xml","form_type":"4"}},{"id":1071283,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":51937,"kind":"person","name":"Bolton Sheryle","position":1,"cik":"0001418947","reported_name":"Bolton Sheryle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-08-08T22:45:21.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in a series of four (4) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the grant date, such that 100% of the stock option will be vested upon the first anniversary of the grant date."}],"balance_after":12500,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001683168-25-005832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1418947/000168316825005832/ownership.xml","form_type":"4"}},{"id":1071799,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":76792,"kind":"person","name":"Zikria Dean","position":1,"cik":"0001877611","reported_name":"Zikria Dean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-08-08T18:46:44.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in a series of four (4) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the grant date, such that 100% of the stock option will be vested upon the first anniversary of the grant date."}],"balance_after":7500,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001683168-25-005837","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877611/000168316825005837/ownership.xml","form_type":"4"}},{"id":1071469,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Purchase)","published_at":"2025-08-08T18:45:37.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as follows: (i) 50% upon the first anniversary of the grant date, and (ii) the remaining 50% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."}],"balance_after":85000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001683168-25-005833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316825005833/ownership.xml","form_type":"4"}},{"id":1249416,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-24T22:01:03.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 600,000 restricted stock units granted to the Reporting Person outside of the Issuer's Amended and Restated 2021 Equity Incentive Plan (the \"Plan\"), in connection with, and as a material inducement to, the hiring and appointment of the Reporting Person as Chief Operating Officer of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty percent (25%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":600000,"derivative":{"expiration_date":"2035-02-17","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001683168-25-001207","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316825001207/ownership.xml","form_type":"4"}},{"id":1323786,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":84854,"kind":"person","name":"Gurfein Blake","position":1,"cik":"0001891888","reported_name":"Gurfein Blake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2024-12-20T22:15:08.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."}],"balance_after":225000,"derivative":{"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001683168-24-008901","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000168316824008901/ownership.xml","form_type":"4"}},{"id":1324263,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":36847,"kind":"person","name":"Wolf Lisa G","position":1,"cik":"0001861556","reported_name":"Wolf Lisa G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Restricted Stock Units","published_at":"2024-12-20T22:15:06.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."}],"balance_after":25000,"derivative":{"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-24-008899","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861556/000168316824008899/ownership.xml","form_type":"4"}},{"id":1323988,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":51937,"kind":"person","name":"Bolton Sheryle","position":1,"cik":"0001418947","reported_name":"Bolton Sheryle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2024-12-20T22:15:05.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option Shares will vest and become exercisable in a series of twelve (12) successive equal monthly installments, rounded downward to the nearest whole share, measured from the Vesting Commencement Date, such that 100% of the Option Shares will be vested and exercisable upon the first (1st) anniversary of the Vesting Commencement Date."}],"balance_after":15000,"derivative":{"exercise_price":0.226,"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001683168-24-008898","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1418947/000168316824008898/ownership.xml","form_type":"4"}},{"id":1324388,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":30150,"kind":"person","name":"Valauri Christina Rizopoulos","position":1,"cik":"0002005448","reported_name":"Valauri Christina Rizopoulos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2024-12-20T22:15:03.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option Shares will vest and become exercisable in a series of twelve (12) successive equal monthly installments, rounded downward to the nearest whole share, measured from the Vesting Commencement Date, such that 100% of the Option Shares will be vested and exercisable upon the first (1st) anniversary of the Vesting Commencement Date."}],"balance_after":12000,"derivative":{"exercise_price":0.226,"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001683168-24-008897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005448/000168316824008897/ownership.xml","form_type":"4"}},{"id":1324797,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":76792,"kind":"person","name":"Zikria Dean","position":1,"cik":"0001877611","reported_name":"Zikria Dean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2024-12-20T17:15:10.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option Shares will vest and become exercisable in a series of twelve (12) successive equal monthly installments, rounded downward to the nearest whole share, measured from the Vesting Commencement Date, such that 100% of the Option Shares will be vested and exercisable upon the first (1st) anniversary of the Vesting Commencement Date."}],"balance_after":12000,"derivative":{"exercise_price":0.226,"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001683168-24-008902","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877611/000168316824008902/ownership.xml","form_type":"4"}},{"id":1324341,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-12-20T17:15:07.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."}],"balance_after":500000,"derivative":{"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001683168-24-008900","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000168316824008900/ownership.xml","form_type":"4"}},{"id":1434989,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":30150,"kind":"person","name":"Valauri Christina Rizopoulos","position":1,"cik":"0002005448","reported_name":"Valauri Christina Rizopoulos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-08-13T21:52:21.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in a series of twelve (12) successive equal monthly installments, rounded downward to the nearest whole share, from the grant date, such that 100% of the option will be vested upon the first anniversary of the grant date."}],"balance_after":3000,"derivative":{"exercise_price":0.41,"expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000950170-24-096483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005448/000095017024096483/ownership.xml","form_type":"4"}},{"id":1434735,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":51937,"kind":"person","name":"Bolton Sheryle","position":1,"cik":"0001418947","reported_name":"Bolton Sheryle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-08-13T21:48:46.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in a series of twelve (12) successive equal monthly installments, rounded downward to the nearest whole share, from the grant date, such that 100% of the option will be vested upon the first anniversary of the grant date."}],"balance_after":3000,"derivative":{"exercise_price":0.41,"expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000950170-24-096480","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1418947/000095017024096480/ownership.xml","form_type":"4"}},{"id":1434532,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-08-13T21:41:59.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in a series of twelve (12) successive equal monthly installments, rounded downward to the nearest whole share, from the grant date, such that 100% of the option will be vested upon the first anniversary of the grant date."}],"balance_after":3000,"derivative":{"exercise_price":0.41,"expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000950170-24-096472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1504699/000095017024096472/ownership.xml","form_type":"4"}},{"id":1435350,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":76792,"kind":"person","name":"Zikria Dean","position":1,"cik":"0001877611","reported_name":"Zikria Dean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-08-13T17:48:23.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in a series of twelve (12) successive equal monthly installments, rounded downward to the nearest whole share, from the grant date, such that 100% of the option will be vested upon the first anniversary of the grant date."}],"balance_after":3000,"derivative":{"exercise_price":0.41,"expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000950170-24-096479","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877611/000095017024096479/ownership.xml","form_type":"4"}},{"id":1562965,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":87053,"kind":"person","name":"Bambach Kimberly Ann","position":1,"cik":"0001977203","reported_name":"Bambach Kimberly Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2024-03-22T22:50:50.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0000950170-24-035557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000095017024035557/ownership.xml","form_type":"4"}},{"id":1562964,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":84854,"kind":"person","name":"Gurfein Blake","position":1,"cik":"0001891888","reported_name":"Gurfein Blake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-22T22:49:39.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 50% on the first anniversary of the grant date and (ii) the remaining 50% in 12 equal monthly installments over the 12 months thereafter."}],"balance_after":10000,"derivative":{"exercise_price":1.34,"expiration_date":"2034-03-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-24-035555","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000095017024035555/ownership.xml","form_type":"4"}},{"id":1563620,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-22T18:47:56.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 50% on the first anniversary of the grant date and (ii) the remaining 50% in 12 equal monthly installments over the 12 months thereafter."}],"balance_after":32000,"derivative":{"exercise_price":1.34,"expiration_date":"2034-03-11","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0000950170-24-035553","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000095017024035553/ownership.xml","form_type":"4"}},{"id":1851570,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-16T21:30:13.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.09,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-23-015786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1504699/000089924323015786/doc4.xml","form_type":"4"}},{"id":1851932,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":51937,"kind":"person","name":"Bolton Sheryle","position":1,"cik":"0001418947","reported_name":"Bolton Sheryle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-16T21:30:07.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.09,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-23-015784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1418947/000089924323015784/doc4.xml","form_type":"4"}},{"id":1853359,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":76792,"kind":"person","name":"Zikria Dean","position":1,"cik":"0001877611","reported_name":"Zikria Dean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-16T17:30:09.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.09,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-23-015785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877611/000089924323015785/doc4.xml","form_type":"4"}},{"id":1897774,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":113665,"kind":"person","name":"Sabia Ryan","position":1,"cik":"0001892415","reported_name":"Sabia Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-05-10T22:44:55.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the 36 months thereafter."}],"balance_after":100000,"derivative":{"exercise_price":0.13,"expiration_date":"2033-05-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-012534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000089924323012534/doc4.xml","form_type":"4"}},{"id":1897773,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":84854,"kind":"person","name":"Gurfein Blake","position":1,"cik":"0001891888","reported_name":"Gurfein Blake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-05-10T22:43:52.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the 36 months thereafter."}],"balance_after":100000,"derivative":{"exercise_price":0.13,"expiration_date":"2033-05-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-012533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000089924323012533/doc4.xml","form_type":"4"}},{"id":1898323,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-05-10T18:46:26.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the 36 months thereafter."}],"balance_after":125000,"derivative":{"exercise_price":0.13,"expiration_date":"2033-05-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-23-012535","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000089924323012535/doc4.xml","form_type":"4"}},{"id":2015369,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-14T23:34:22.000Z","date":"2022-05-16","kind":"other","acquired":false,"shares":15111,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Drexler Family Trust U/D/T dated May 23, 1996"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution from Astia Angels Tivic LLC, of which the reporting person was a member, in connection with the dissolution of such entity."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a pro rata distribution from Astia Angels Tivic LLC, of which the reporting person was a member, in connection with the dissolution of such entity."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Drexler Family Trust U/D/T dated May 23, 1996, and indirectly by the reporting person as trustee of such trust."}],"balance_after":18076,"source":{"system":"sec-edgar","filing":"0000899243-23-005056","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1504699/000089924323005056/doc5.xml","form_type":"5"}},{"id":2225279,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":51937,"kind":"person","name":"Bolton Sheryle","position":1,"cik":"0001418947","reported_name":"Bolton Sheryle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-21T21:24:47.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Amendment No. 1 (\"Form 4/A\") to the Form 4 filed by the reporting person on June 16, 2022 (the \"Original Form 4\") is being filed to correct an administrative error, resulting in the incorrect versting schedule being included for the option. As reflected in this Form 4/A, the option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-22-073073","document":"tm2218957-3_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1418947/000110465922073073/tm2218957-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-06-16"}},{"id":2225031,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-21T21:23:54.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Amendment No. 1 (\"Form 4/A\") to the Form 4 filed by the reporting person on June 16, 2022 (the \"Original Form 4\") is being filed to correct an administrative error, resulting in the incorrect versting schedule being included for the option. As reflected in this Form 4/A, the option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-22-073071","document":"tm2218957-2_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1504699/000110465922073071/tm2218957-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-06-16"}},{"id":2226234,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":76792,"kind":"person","name":"Zikria Dean","position":1,"cik":"0001877611","reported_name":"Zikria Dean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-21T17:23:35.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Amendment No. 1 (\"Form 4/A\") to the Form 4 filed by the reporting person on June 16, 2022 (the \"Original Form 4\") is being filed to correct an administrative error, resulting in the incorrect versting schedule being included for the option. As reflected in this Form 4/A, the option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-22-073070","document":"tm2218957-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877611/000110465922073070/tm2218957-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-06-16"}},{"id":2229605,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-16T23:47:32.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 50% one year from the grant date, and (ii) the remaining 50% in equal monthly installments over the next 24 months."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-22-072045","document":"tm2218712-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1504699/000110465922072045/tm2218712-3_4seq1.xml","form_type":"4"}},{"id":2229849,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":51937,"kind":"person","name":"Bolton Sheryle","position":1,"cik":"0001418947","reported_name":"Bolton Sheryle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-16T23:45:38.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 50% one year from the grant date, and (ii) the remaining 50% in equal monthly installments over the next 24 months."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-22-072043","document":"tm2218712-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1418947/000110465922072043/tm2218712-2_4seq1.xml","form_type":"4"}},{"id":2230653,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":76792,"kind":"person","name":"Zikria Dean","position":1,"cik":"0001877611","reported_name":"Zikria Dean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-16T19:44:42.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 50% one year from the grant date, and (ii) the remaining 50% in equal monthly installments over the next 24 months."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-22-072042","document":"tm2218712-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877611/000110465922072042/tm2218712-1_4seq1.xml","form_type":"4"}},{"id":2304761,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":128313,"kind":"person","name":"Cai Veronica","position":1,"cik":"0001801322","reported_name":"Cai Veronica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-04-05T17:15:04.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":117880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the 36 months thereafter."}],"balance_after":117880,"derivative":{"exercise_price":1.61,"expiration_date":"2032-03-31","underlying":"Common Stock","underlying_shares":117880},"source":{"system":"sec-edgar","filing":"0001104659-22-042855","document":"tm2211723d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801322/000110465922042855/tm2211723d2_4.xml","form_type":"4"}},{"id":2407769,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":113665,"kind":"person","name":"Sabia Ryan","position":1,"cik":"0001892415","reported_name":"Sabia Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-08T22:35:49.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months."}],"balance_after":50000,"derivative":{"exercise_price":1.67,"expiration_date":"2032-02-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-22-014171","document":"tm225821d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000110465922014171/tm225821d3_4.xml","form_type":"4"}},{"id":2407768,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":84854,"kind":"person","name":"Gurfein Blake","position":1,"cik":"0001891888","reported_name":"Gurfein Blake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-08T22:32:47.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months."}],"balance_after":35000,"derivative":{"exercise_price":1.67,"expiration_date":"2032-02-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-22-014161","document":"tm225821d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000110465922014161/tm225821d1_4.xml","form_type":"4"}},{"id":2408678,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-08T17:34:19.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months."}],"balance_after":200000,"derivative":{"exercise_price":1.83,"expiration_date":"2027-02-03","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-22-014166","document":"tm225821d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000110465922014166/tm225821d2_4.xml","form_type":"4"}},{"id":2469552,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-17T01:39:19.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest one year from the grant date."}],"balance_after":18000,"derivative":{"exercise_price":4.59,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-21-150715","document":"tm2135733d5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1504699/000110465921150715/tm2135733d5_4.xml","form_type":"4"}},{"id":2469374,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":84854,"kind":"person","name":"Gurfein Blake","position":1,"cik":"0001891888","reported_name":"Gurfein Blake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-17T01:38:48.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months."}],"balance_after":82500,"derivative":{"exercise_price":4.59,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001104659-21-150714","document":"tm2135733d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000110465921150714/tm2135733d4_4.xml","form_type":"4"}},{"id":2469373,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":113665,"kind":"person","name":"Sabia Ryan","position":1,"cik":"0001892415","reported_name":"Sabia Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Sales and Operations"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-17T01:37:52.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months."}],"balance_after":25000,"derivative":{"exercise_price":4.59,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-21-150712","document":"tm2135733d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000110465921150712/tm2135733d2_4.xml","form_type":"4"}},{"id":2469711,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":51937,"kind":"person","name":"Bolton Sheryle","position":1,"cik":"0001418947","reported_name":"Bolton Sheryle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-17T01:37:22.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest one year from the grant date."}],"balance_after":18000,"derivative":{"exercise_price":4.59,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-21-150711","document":"tm2135733d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1418947/000110465921150711/tm2135733d1_4.xml","form_type":"4"}},{"id":2470728,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":76792,"kind":"person","name":"Zikria Dean","position":1,"cik":"0001877611","reported_name":"Zikria Dean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-16T20:38:23.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest one year from the grant date."}],"balance_after":18000,"derivative":{"exercise_price":4.59,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-21-150713","document":"tm2135733d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877611/000110465921150713/tm2135733d3_4.xml","form_type":"4"}},{"id":2513140,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Promissory Note","published_at":"2021-11-15T21:11:31.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"price":0,"reported_value":101200,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the \"Note\"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the \"Note\"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the \"Note\"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Note was scheduled to mature on June 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":3.75,"underlying":"Common Stock","underlying_shares":26986},"source":{"system":"sec-edgar","filing":"0001104659-21-139507","document":"tm2133057-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000110465921139507/tm2133057-1_4seq1.xml","form_type":"4"}},{"id":2513139,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series Seed-2 Convertible Preferred Stock","published_at":"2021-11-15T21:11:31.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the \"IPO\"). The Series Seed-2 Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the \"IPO\"). The Series Seed-2 Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the \"IPO\"). The Series Seed-2 Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"exercise_date":"2021-03-01","underlying":"Common Stock","underlying_shares":1391},"source":{"system":"sec-edgar","filing":"0001104659-21-139507","document":"tm2133057-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000110465921139507/tm2133057-1_4seq1.xml","form_type":"4"}},{"id":2513138,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-15T21:11:31.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":26986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the \"Note\"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the \"Note\"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount."}],"balance_after":1199877,"source":{"system":"sec-edgar","filing":"0001104659-21-139507","document":"tm2133057-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000110465921139507/tm2133057-1_4seq1.xml","form_type":"4"}},{"id":2513137,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":70989,"kind":"person","name":"Ernst Jennifer","position":1,"cik":"0001889915","reported_name":"Ernst Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-15T21:11:31.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":1391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the \"IPO\"). The Series Seed-2 Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the \"IPO\"). The Series Seed-2 Convertible Preferred Stock had no expiration date."}],"balance_after":1172891,"source":{"system":"sec-edgar","filing":"0001104659-21-139507","document":"tm2133057-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889915/000110465921139507/tm2133057-1_4seq1.xml","form_type":"4"}}]}